Abstract 3066
Background
Despite combined antiretroviral therapy, risk of anal cancer is eighty times higher in HIV1-MSM than in general population. Although no international consensus exist for routine screening of anal cancer for HIV1-MSM, guidelines in most western countries include at least digital examination and suggest that anal Pap test may be beneficial to diagnose high grade squamous intraepithelial lesion. This monocentric cross-sectional study aims to describe HIV1-MSM knowledge and attitudes towards anal cancer screening (ACS).
Methods
All adult patients (pts) HIV1-MSM who went to the Hôpital Européen Georges Pompidou in Paris (France) for a consultation were invited to complete a self-administered questionnaire about their knowledge regarding ACS and their previous experience. We explored factors associated with previous screening uptake, among patients familiar with ACS, with multivariable logistic regression.
Results
Among an active list comprising 1019 pts HIV1-MSM, 410 completed the questionnaire between June 2015 and January 2016. Median age was 50 years (iqr, 42.5-57.5) and median time from HIV diagnosis was 14.2 years (iqr, 6.9-23.1). HIV viral load was
Conclusions
Although 82% of the HIV1-MSM were familiar with ACS, only 57% of them have already taken a screening test. Information by physician seems the best intervention to promote the screening. Encouraging physicians to inform HIV1-MSM pts on anal cancer may improve ACS uptake. Moreover, more detailed information and better accessibility of screening centers should help improve screening rate.
Clinical trial identification
Legal entity responsible for the study
APHP
Funding
APHP
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
What does society value about oncology drugs? A discrete choice experiment in the Belgian population
Presenter: Kim Pauwels
Session: Public health and health economics
Resources:
Abstract
The ESMO-Magnitude of Clinical Benefit Scale (MCBS) in rare tumor entities: A real life experience at the Medical University Vienna
Presenter: Barbara Kiesewetter
Session: Public health and health economics
Resources:
Abstract
Presentation
Webcast
The effect of financial difficulties on clinical outcomes in Italian cancer patients: A pooled analysis of 16 academic prospective clinical trials
Presenter: Francesco Perrone
Session: Public health and health economics
Resources:
Abstract
Single-arm trials for cancer drug approval and patient access
Presenter: Jorge Martinalbo
Session: Public health and health economics
Resources:
Abstract
Second cancer screening among 5-years women cancer survivors (French National Survey VICAN5)
Presenter: Marc Bendiane
Session: Public health and health economics
Resources:
Abstract
More than 5000 patients with metastatic melanoma in Europe per year do not have access to new life-saving drugs
Presenter: Lidija Kandolf Sekulovic
Session: Public health and health economics
Resources:
Abstract
Invited discussant abstracts 1020O_PR and 1389O_PR
Presenter: Alberto Ocana Fernandez
Session: Public health and health economics
Resources:
Presentation
Webcast
Invited discussant
Presenter: Tit Albreht
Session: Public health and health economics
Resources:
Presentation
Webcast
Factors affecting job retention amongst cancer survivors five years after diagnosis: evidence from the French VICAN survey
Presenter: Caroline Alleaume
Session: Public health and health economics
Resources:
Abstract
EMA support for early access for oncology products
Presenter: Steffen Thirstrup
Session: Public health and health economics
Resources:
Abstract